EGFR induces miR-96 by a physical interaction at the promoter region of miR-96.
miR-96 targets to ETV6 transcript and reduces its stability.
ETV6 is downregulated by EGFR-miR-96 signaling.
The reduced ETV6 levels are associated with malignant prostate cancer.
ETV6 acts as a tumor suppressor inhibiting prostate cancer metastasis.